Chronic Idiopathic Thrombocytopenic Purpura during the Pregnancy: A Case Report

    Published on:June 2022
    Journal of Young Pharmacists, 2022; 14(2):261-262
    Case Report | doi:10.5530/jyp.2022.14.51
    Authors:

    Kommuri Vyduryam, T Vinay Kumar*, Sreya Kosanam, Shaik Asha Begum, Namala Venkata Yaseswi, Vesapogu Pravalika

    Department of Pharmacology and Pharmacy Practice, Nirmala College of Pharmacy, Mangalagiri, Andhra Pradesh, INDIA.

    Abstract:

    A 37-year-old woman was admitted to the hospital after complaining of a petechiae rash all over her body for three days, generalized weakness, pallor, and gum bleeding in one episode, and a history of similar episodes in the past. The patient has Idiopathic Thrombocytopenic Purpura and has been on medication throughout her pregnancy. Peripheral examination reveals microcytic hypochromic anemia with thrombocytopenia, and bone marrow examination reveals an increase in the number of megakaryocytes. She received corticosteroid and antifibrinolytic treatment. Her symptoms are similar to those caused by steroids after being readmitted to the hospital. Idiopathic Thrombocytopenic Purpura appears to be an immune-mediated disease. Although Idiopathic Thrombocytopenic Purpura is a rare condition, it can be fatal, especially during pregnancy because of fetal intracranial hemorrhage.

    Key words: Idiopathic Thrombocytopenia, Petechiae, Pregnancy, Megakaryocytes, Antifibrinolytic.

    Article Download

     

    Navigation